CN111032088A - 大麻二酚酸酯类组合物及其用途 - Google Patents
大麻二酚酸酯类组合物及其用途 Download PDFInfo
- Publication number
- CN111032088A CN111032088A CN201880041597.0A CN201880041597A CN111032088A CN 111032088 A CN111032088 A CN 111032088A CN 201880041597 A CN201880041597 A CN 201880041597A CN 111032088 A CN111032088 A CN 111032088A
- Authority
- CN
- China
- Prior art keywords
- branched
- straight
- compound
- disease
- cbda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/16—Acetic acid esters of dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/28—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with dihydroxylic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762522243P | 2017-06-20 | 2017-06-20 | |
US62/522,243 | 2017-06-20 | ||
PCT/IL2018/050678 WO2018235079A1 (en) | 2017-06-20 | 2018-06-20 | CANNABIDIOLIC ACID ESTER COMPOSITIONS AND USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111032088A true CN111032088A (zh) | 2020-04-17 |
Family
ID=62875079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880041597.0A Pending CN111032088A (zh) | 2017-06-20 | 2018-06-20 | 大麻二酚酸酯类组合物及其用途 |
Country Status (12)
Country | Link |
---|---|
US (1) | US11440870B2 (zh) |
EP (1) | EP3509638B1 (zh) |
JP (1) | JP2020524679A (zh) |
CN (1) | CN111032088A (zh) |
AU (1) | AU2018287018B2 (zh) |
BR (1) | BR112019026916A2 (zh) |
CA (1) | CA3067512A1 (zh) |
DK (1) | DK3509638T3 (zh) |
ES (1) | ES2909350T3 (zh) |
MX (1) | MX2019015311A (zh) |
PT (1) | PT3509638T (zh) |
WO (1) | WO2018235079A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
AU2018287018B2 (en) | 2017-06-20 | 2022-04-28 | University Of Guelph | Cannabidiolic acid esters compositions and uses thereof |
EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | CANNABIGEROL SYNTHESIS |
JP2022516845A (ja) * | 2018-12-25 | 2022-03-03 | イーピーエム(アイピー), インコーポレイテッド | 化粧品用または食用組成物のためのカンナビジオール酸エステル |
MX2021010875A (es) * | 2019-03-12 | 2021-12-10 | Epm Ip Inc | Composiciones de éster de ácido cannabinoide y sus usos. |
MX2022002183A (es) | 2019-08-22 | 2022-05-24 | Epm Group Inc | Composiciones de éster de ácido cannabinoide y sus usos. |
WO2021137224A1 (en) * | 2020-01-01 | 2021-07-08 | Epm Group, Inc. | Cannabidiolic acid esters for treating muscular dystrophy |
IL275108A (en) * | 2020-06-03 | 2022-01-01 | Epm Ip Inc | Abnormal acid cannabidiol (abn-cbd) derivatives and their uses |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
CA3198547A1 (en) * | 2020-11-16 | 2022-05-19 | Mark RIDALL | Rapidly infusing platform and compositions for therapeutic treatment in humans |
IL303739A (en) * | 2020-12-24 | 2023-08-01 | Buzzelet Development And Technologies Ltd | Compositions including cannabinoid esters |
US20230066947A1 (en) * | 2021-08-04 | 2023-03-02 | Max Hammond | Method for the augmentation of substance abuse therapies using cannabinoid formulations |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100298579A1 (en) * | 2009-04-29 | 2010-11-25 | Thc Pharm Gmbh | Process for preparing synthetic cannabinoids |
WO2015158381A1 (en) * | 2014-04-16 | 2015-10-22 | Vivacell Biotechnology España S.L. | Novel cannabidiol quinone derivatives |
US20150336874A1 (en) * | 2013-09-03 | 2015-11-26 | Symrise Ag | Mixtures of cannabinoid compounds, and production and use thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2318468A1 (fr) * | 1975-07-17 | 1977-02-11 | Jaeger | Dispositif electronique d'enregistrement et de lecture de donnees concernant differents parametres au cours d'un cycle predetermine, fonction de l'un desdits parametres |
US5342971A (en) | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
DE69920683T2 (de) | 1998-05-04 | 2005-04-07 | The University Of Connecticut, Farmington | Selektiv auf den CB2-Rezeptor wirkende Cannabinoide |
IL136839A (en) | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
JP2008502690A (ja) | 2004-06-15 | 2008-01-31 | アンドリュー シァン チェン, | リン脂質組成物ならびにその調製方法および使用方法 |
EP2578577A1 (en) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof |
CN101384012B (zh) * | 2008-10-22 | 2012-05-23 | 华为终端有限公司 | 系统端和终端的交互媒体文档更新方法及装置 |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
GB2531283A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiols in the treatment of degenerative skeletal muscle diseases |
EP3061450A1 (de) | 2015-02-26 | 2016-08-31 | Symrise AG | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
CN106810426B (zh) * | 2016-12-29 | 2020-05-08 | 暨明医药科技(苏州)有限公司 | 一种大麻二酚的合成方法 |
AU2018287018B2 (en) | 2017-06-20 | 2022-04-28 | University Of Guelph | Cannabidiolic acid esters compositions and uses thereof |
WO2019234728A1 (en) | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
-
2018
- 2018-06-20 AU AU2018287018A patent/AU2018287018B2/en active Active
- 2018-06-20 DK DK18739958.9T patent/DK3509638T3/da active
- 2018-06-20 EP EP18739958.9A patent/EP3509638B1/en active Active
- 2018-06-20 MX MX2019015311A patent/MX2019015311A/es unknown
- 2018-06-20 JP JP2019570108A patent/JP2020524679A/ja active Pending
- 2018-06-20 CN CN201880041597.0A patent/CN111032088A/zh active Pending
- 2018-06-20 PT PT187399589T patent/PT3509638T/pt unknown
- 2018-06-20 BR BR112019026916-9A patent/BR112019026916A2/pt not_active Application Discontinuation
- 2018-06-20 WO PCT/IL2018/050678 patent/WO2018235079A1/en unknown
- 2018-06-20 CA CA3067512A patent/CA3067512A1/en active Pending
- 2018-06-20 US US16/343,050 patent/US11440870B2/en active Active
- 2018-06-20 ES ES18739958T patent/ES2909350T3/es active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100298579A1 (en) * | 2009-04-29 | 2010-11-25 | Thc Pharm Gmbh | Process for preparing synthetic cannabinoids |
US20150336874A1 (en) * | 2013-09-03 | 2015-11-26 | Symrise Ag | Mixtures of cannabinoid compounds, and production and use thereof |
CN105517989A (zh) * | 2013-09-03 | 2016-04-20 | 西姆莱斯有限公司 | 大麻素类化合物的混合物及其制备和用途 |
WO2015158381A1 (en) * | 2014-04-16 | 2015-10-22 | Vivacell Biotechnology España S.L. | Novel cannabidiol quinone derivatives |
Also Published As
Publication number | Publication date |
---|---|
EP3509638A1 (en) | 2019-07-17 |
ES2909350T3 (es) | 2022-05-06 |
US20200115317A1 (en) | 2020-04-16 |
WO2018235079A1 (en) | 2018-12-27 |
JP2020524679A (ja) | 2020-08-20 |
AU2018287018B2 (en) | 2022-04-28 |
AU2018287018A1 (en) | 2020-01-30 |
MX2019015311A (es) | 2022-02-02 |
EP3509638B1 (en) | 2022-01-12 |
US11440870B2 (en) | 2022-09-13 |
DK3509638T3 (da) | 2022-04-11 |
PT3509638T (pt) | 2022-03-02 |
BR112019026916A2 (pt) | 2020-06-30 |
CA3067512A1 (en) | 2018-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111032088A (zh) | 大麻二酚酸酯类组合物及其用途 | |
ES2708808T3 (es) | Tetrahidrocannabivarina para uso en el tratamiento de náuseas y vómitos | |
JP2009538893A (ja) | カンナビノイドの新規な使用 | |
AU2017292818B2 (en) | Solid forms of an sGC stimulator | |
CN108463224A (zh) | sGC刺激剂用于胃肠功能障碍治疗的应用 | |
JP2019534327A (ja) | sGC刺激薬による中枢神経系疾患の治療 | |
Li et al. | Design, synthesis, and biological evaluation of low-toxic lappaconitine derivatives as potential analgesics | |
AU2017291826A1 (en) | Phosphorus prodrugs of sgc stimulators | |
EP2991733A1 (en) | Cannabidiol for the prevention and treatment of graft-versus-host disease | |
Rock et al. | Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid | |
CN101379063A (zh) | 3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途 | |
Class et al. | Patent application title: CANNABIDIOLIC ACID ESTERS COMPOSITIONS AND USES THEREOF Inventors: Raphael Mechoulam (Jerusalem, IL) Linda Parker (Campbell River, British Columbia, CA) Roger Pertwee (Aberdeen, Scotland, GB) Aron Weller (Shoham, IL) Joseph Tam (Jerusalem, IL) Christeen Haj (Nazareth Hit, IL) Reem Smoum (Jerusalem, IL) | |
WO2022103635A1 (en) | Rapidly infusing platform and compositions for therapeutic treatment in humans | |
MX2012002551A (es) | Compuestos para tratar desordenes o enfermedades asociados con la actividad del receptor de neuroquinina 2. | |
US20230218567A1 (en) | Compound and method for treating diseases and disorders | |
PIĄTKOWSKA-CHMIEL et al. | THE ANALGESIC EFFECT OF 1, 3-THIAZOLIDIN-4-ONE DERIVATIVES AS POTENTIAL MODULATORS OF THE SEROTONINERGIC SYSTEM. | |
CN102503953B (zh) | 肟类化合物 | |
WO2023224960A1 (en) | Rapidly infusing cannabinoid compositions, processes of manufacture, and methods of use | |
KR20210054854A (ko) | 마약 중독 예방 또는 치료용 약학조성물 | |
JP2009531436A (ja) | 認知障害および他の障害の治療方法 | |
Rock | Cannabidiol Indirectly Activates 5-HT1A Somatodendritic Autoreceptors to Attenuate Vomiting and Nausea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200529 Address after: Israel Jerusalem Applicant after: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM Ltd. Applicant after: University OF GUELPH Address before: Israel Jerusalem Applicant before: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM Ltd. Applicant before: University OF GUELPH Applicant before: BAR-ILAN University |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40028173 Country of ref document: HK |